UK cell and gene therapy firms are worried a shortage of skilled manufacturing staff will slow growth with some concerned Brexit will exacerbate the problem. The findings come from a new skills survey by the Cell and Gene Therapy Catapult (CGTC) – an organisation set up to support the sector by non-departmental government body, Innovate UK. Of the 41 companies that responded, 98% said they planned to expand their headcount over the next five years. Of these, 83% raised concerns…